These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 32788708)

  • 1. The type I interferon response in COVID-19: implications for treatment.
    Lee JS; Shin EC
    Nat Rev Immunol; 2020 Oct; 20(10):585-586. PubMed ID: 32788708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.
    Yeleswaram S; Smith P; Burn T; Covington M; Juvekar A; Li Y; Squier P; Langmuir P
    Clin Immunol; 2020 Sep; 218():108517. PubMed ID: 32585295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19.
    Spinelli FR; Conti F; Gadina M
    Sci Immunol; 2020 May; 5(47):. PubMed ID: 32385052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 6. What is the role of rheumatologists in the era of COVID-19?
    Marotto D; Sarzi-Puttini P
    Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
    [No Abstract]   [Full Text] [Related]  

  • 7. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
    Richardson P; Griffin I; Tucker C; Smith D; Oechsle O; Phelan A; Rawling M; Savory E; Stebbing J
    Lancet; 2020 Feb; 395(10223):e30-e31. PubMed ID: 32032529
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue damage from neutrophil-induced oxidative stress in COVID-19.
    Laforge M; Elbim C; Frère C; Hémadi M; Massaad C; Nuss P; Benoliel JJ; Becker C
    Nat Rev Immunol; 2020 Sep; 20(9):515-516. PubMed ID: 32728221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
    Cingolani A; Tummolo AM; Montemurro G; Gremese E; Larosa L; Cipriani MC; Pasciuto G; Liperoti R; Murri R; Pirronti T; Cauda R; Fantoni M;
    Infection; 2020 Oct; 48(5):767-771. PubMed ID: 32642806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 revisiting inflammatory pathways of arthritis.
    Schett G; Manger B; Simon D; Caporali R
    Nat Rev Rheumatol; 2020 Aug; 16(8):465-470. PubMed ID: 32561873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 herd immunity: where are we?
    Fontanet A; Cauchemez S
    Nat Rev Immunol; 2020 Oct; 20(10):583-584. PubMed ID: 32908300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plea for the pathogenic role of immune complexes in severe Covid-19.
    Vuitton DA; Vuitton L; Seillès E; Galanaud P
    Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
    [No Abstract]   [Full Text] [Related]  

  • 13. [Not Available].
    Balavoine JF
    Rev Med Suisse; 2020 May; 16(695):1126. PubMed ID: 32462848
    [No Abstract]   [Full Text] [Related]  

  • 14. How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.
    Ledford H
    Nature; 2020 Apr; 580(7803):311-312. PubMed ID: 32273618
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on.
    Lipworth B; Chan R; Kuo CR
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):503-504. PubMed ID: 32585180
    [No Abstract]   [Full Text] [Related]  

  • 16. The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.
    La Rosée F; Bremer HC; Gehrke I; Kehr A; Hochhaus A; Birndt S; Fellhauer M; Henkes M; Kumle B; Russo SG; La Rosée P
    Leukemia; 2020 Jul; 34(7):1805-1815. PubMed ID: 32518419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not just antibodies: B cells and T cells mediate immunity to COVID-19.
    Cox RJ; Brokstad KA
    Nat Rev Immunol; 2020 Oct; 20(10):581-582. PubMed ID: 32839569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After 62 years of regulating immunity, dexamethasone meets COVID-19.
    Cain DW; Cidlowski JA
    Nat Rev Immunol; 2020 Oct; 20(10):587-588. PubMed ID: 32778829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune status could determine efficacy of COVID-19 therapies.
    Cully M
    Nat Rev Drug Discov; 2020 Jul; 19(7):431-434. PubMed ID: 32546768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.